Morgan Stanley’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.61K | Hold |
2,616
| – | – | ﹤0.01% | 7288 |
|
|
2026
Q1 | $2.39K | Sell |
2,616
-16,035
| -86% | -$16.8K | ﹤0.01% | 7298 |
|
|
2025
Q4 | $21.1K | Buy |
18,651
+16,704
| +858% | +$23.5K | ﹤0.01% | 6683 |
|
|
2025
Q3 | $2.78K | Hold |
1,947
| – | – | ﹤0.01% | 7235 |
|
|
2025
Q2 | $2.73K | Buy |
1,947
+1,831
| +1,578% | +$2.5K | ﹤0.01% | 7164 |
|
|
2025
Q1 | $136 | Hold |
116
| – | – | ﹤0.01% | 7523 |
|
|
2024
Q4 | $166 | Sell |
116
-145
| -56% | -$208 | ﹤0.01% | 7428 |
|
|
2024
Q3 | $392 | Sell |
261
-1,000
| -79% | -$1.86K | ﹤0.01% | 7324 |
|
|
2024
Q2 | $2.17K | Buy |
1,261
+1,024
| +432% | +$1.82K | ﹤0.01% | 7051 |
|
|
2024
Q1 | $275 | Hold |
237
| – | – | ﹤0.01% | 7286 |
|
|
2023
Q4 | $242 | Hold |
237
| – | – | ﹤0.01% | 7285 |
|
|
2023
Q3 | $318 | Hold |
237
| – | – | ﹤0.01% | 7354 |
|
|
2023
Q2 | $273 | Buy |
237
+150
| +172% | +$181 | ﹤0.01% | 7427 |
|
|
2023
Q1 | $102 | Hold |
87
| – | – | ﹤0.01% | 7570 |
|
|
2022
Q4 | $97 | Sell |
87
-23,682
| -100% | -$36.9K | ﹤0.01% | 7697 |
|
|
2022
Q3 | $41K | Buy |
23,769
+23,646
| +19,224% | +$51.6K | ﹤0.01% | 6493 |
|
|
2022
Q2 | $0 | Sell |
123
-637
| -84% | -$1.17K | ﹤0.01% | 7913 |
|
|
2022
Q1 | $2K | Sell |
760
-543
| -42% | -$1.27K | ﹤0.01% | 7749 |
|
|
2021
Q4 | $5K | Sell |
1,303
-2,150
| -62% | -$9.79K | ﹤0.01% | 7645 |
|
|
2021
Q3 | $16K | Buy |
3,453
+1
| +0% | +$4 | ﹤0.01% | 7178 |
|
|
2021
Q2 | $16K | Hold |
3,452
| – | – | ﹤0.01% | 7073 |
|
|
2021
Q1 | $16K | Sell |
3,452
-4,750
| -58% | -$21.5K | ﹤0.01% | 6801 |
|
|
2020
Q4 | $24K | Sell |
8,202
-21,282
| -72% | -$77.5K | ﹤0.01% | 6378 |
|
|
2020
Q3 | $113K | Sell |
29,484
-25,147
| -46% | -$138K | ﹤0.01% | 5370 |
|
|
2020
Q2 | $409K | Buy |
54,631
+8,154
| +18% | +$56.7K | ﹤0.01% | 4705 |
|
|
2020
Q1 | $267K | Buy |
46,477
+45,324
| +3,931% | +$320K | ﹤0.01% | 4745 |
|
|
2019
Q4 | $3K | Buy |
1,153
+259
| +29% | +$585 | ﹤0.01% | 6465 |
|
|
2019
Q3 | $2K | Buy |
894
+1
| +0.1% | +$4 | ﹤0.01% | 6484 |
|
|
2019
Q2 | $4K | Sell |
893
-18
| -2% | -$92 | ﹤0.01% | 6355 |
|
|
2019
Q1 | $5K | Buy |
911
+218
| +31% | +$1.42K | ﹤0.01% | 6324 |
|
|
2018
Q4 | $3K | Buy |
693
+200
| +41% | +$1.28K | ﹤0.01% | 6378 |
|
|
2018
Q3 | $4K | Sell |
493
-18
| -4% | -$139 | ﹤0.01% | 6479 |
|
|
2018
Q2 | $5K | Buy |
511
+68
| +15% | +$835 | ﹤0.01% | 6438 |
|
|
2018
Q1 | $7K | Sell |
443
-300
| -40% | -$5.55K | ﹤0.01% | 6340 |
|
|
2017
Q4 | $13K | Buy |
743
+529
| +247% | +$10.8K | ﹤0.01% | 6177 |
|
|
2017
Q3 | $5K | Buy |
+214
| New | +$5.75K | ﹤0.01% | 6294 |
|
|
2017
Q1 | – | Sell |
-24
| Closed | -$1K | – | 6594 |
|
|
2016
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 6448 |
|
|
2016
Q3 | $1K | Sell |
24
-224
| -90% | -$7.42K | ﹤0.01% | 6432 |
|
|
2016
Q2 | $8K | Sell |
248
-707
| -74% | -$25.8K | ﹤0.01% | 6109 |
|
|
2016
Q1 | $42K | Buy |
955
+421
| +79% | +$16.3K | ﹤0.01% | 5681 |
|
|
2015
Q4 | $13K | Sell |
534
-253
| -32% | -$6.06K | ﹤0.01% | 6177 |
|
|
2015
Q3 | $19K | Sell |
787
-75
| -9% | -$1.99K | ﹤0.01% | 6064 |
|
|
2015
Q2 | $30K | Buy |
862
+100
| +13% | +$3.81K | ﹤0.01% | 6023 |
|
|
2015
Q1 | $35K | Sell |
762
-1,500
| -66% | -$80K | ﹤0.01% | 5904 |
|
|
2014
Q4 | $123K | Buy |
2,262
+931
| +70% | +$61.6K | ﹤0.01% | 5463 |
|
|
2014
Q3 | $80K | Buy |
1,331
+76
| +6% | +$5.97K | ﹤0.01% | 5561 |
|
|
2014
Q2 | $106K | Sell |
1,255
-215
| -15% | -$15.3K | ﹤0.01% | 5472 |
|
|
2014
Q1 | $94K | Sell |
1,470
-505
| -26% | -$43.2K | ﹤0.01% | 5475 |
|
|
2013
Q4 | $189K | Buy |
+1,975
| New | +$203K | ﹤0.01% | 5056 |
|
Other funds holding NNVC
CCM
MFS
Morgan Stanley's NNVC Position: Q2 2026 in Review
Morgan Stanley held its NanoViricides (NNVC) position steady in Q2 2026 at 2,616 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #7288.
Morgan Stanley first reported a position in NNVC in Q4 2013 and has held it in 49 quarters since. The position peaked at $409K in Q2 2020. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.
- Morgan Stanley held 2,616 shares of NanoViricides worth $3.61K as of Q2 2026.
- Morgan Stanley left its NanoViricides share count unchanged in Q2 2026.
- NanoViricides made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7288 holding.
- Morgan Stanley first reported a position in NanoViricides in Q4 2013 and has held it in 49 quarters since.
- Morgan Stanley's NanoViricides position peaked at $409K in Q2 2020.
- 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.